Companies: 10,795·Total market cap: $144.5T
Bio Essence Corporation

Bio Essence Corporation

BIOEOTCHealthcare● Active
$0.25
$-0.02(-7.85%)
Market Cap$9998638
P/E Ratio—
52W High$0.517
52W Low$0.051
SEC Filings

Bio Essence Corporation (BIOE) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001723059 · BIOE · OTC · as of Jun 10, 2026

Filing snapshot

82
Total Filings
8-K/A
Latest Form
2026-05-19
Most Recent
2022
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001723059 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-27
Fiscal Year End
Mar 27, 2026
Accession No.
0001213900-26-035467
Primary Document
ea0283075-10k_bioessence.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001723059 · Accession 0001213900-26-035467

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2026-05-15
View 10-Q on SEC
8-KCurrent Report
AMENDMENT NO. 1 TO FORM 8-K
2026-05-19Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-K/ACurrent Report (Amended)
AMENDMENT NO. 1 TO FORM 8-K
2026-05-19
View
10-QQuarterly Report
QUARTERLY REPORT
2026-05-15
View
8-KCurrent Report
CURRENT REPORT
2026-04-24
View
10-KAnnual Report
ANNUAL REPORT
2026-03-27
View
QUALIFQUALIF
QUALIF
2026-01-05
View
10-QQuarterly Report
QUARTERLY REPORT
2025-11-12
View
1-A1-A
1-A
2025-10-17
View
10-QQuarterly Report
QUARTERLY REPORT
2025-08-14
View
10-QQuarterly Report
QUARTERLY REPORT
2025-05-15
View
10-KAnnual Report
ANNUAL REPORT
2025-03-28
View
UPLOADUPLOAD
UPLOAD
2024-12-05
View
10-Q/AQuarterly Report (Amended)
AMENDMENT NO. 3 TO FORM 10-Q
2024-11-27
View
10-Q/AQuarterly Report (Amended)
AMENDMENT NO. 3 TO FORM 10-Q
2024-11-27
View
10-QQuarterly Report
QUARTERLY REPORT
2024-11-14
View
UPLOADUPLOAD
UPLOAD
2024-11-08
View
Showing 1–15 of 73 filingsForm 4 / 144 hidden· 82 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001723059  |  Exchange: OTC · Healthcare

Bio Essence Corporation (OTC: BIOE) has submitted 82 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001723059, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Bio Essence Corporation's most comprehensive regulatory disclosure. The most recent Bio Essence Corporation 10-K was filed on 2026-03-27 for fiscal year ending 2026. Historical BIOE 10-K annual reports are available from 2017 through 2026.

Investors researching Bio Essence Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
→ BIOE Financials→ BIOE Earnings→ BIOE Insider Trades

Frequently Asked Questions

BIOE SEC Filings · 8 questions

Bio Essence Corporation (BIOE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 82 filings and access original documents at no cost. Bio Essence Corporation's CIK is 0001723059.

BIOE SEC filingsBio Essence Corporation SEC documentsfind BIOE 10-K